Autoantibody profiling to follow evolution of lupus syndromes

Table 2 Lupus features in study subjects at baseline and follow-up visits

Subject	Baseline SLE criteria*	Follow-up SLE criteria
1	ANA, heme, APL (RF)
2	ANA, arthritis
3	ANA (SSA)
4	ANA, arthritis, Sm
5	ANA
6	ANA (SSA, SSB)
7	ANA, photo, mucosal
8	ANA, photo
9	ANA, arthritis, dsDNA
10	ANA, malar, serositis
11	Arthritis, dsDNA
12	ANA (RF)
13	ANA
14	ANA, arthritis
15	ANA, heme
16	ANA, photo
17	ANA, photo, serositis
18	ANA, discoid, heme
19	ANA, photo (Scl70)
20	ANA, photo, heme, dsDNA**	LN^† class V, mucosal, arthritis, serositis
21	ANA	discoid, photo, APL, heme
22	ANA	malar, discoid, photo, mucosal, arthritis, dsDNA

*Criteria are malar: malar rash; mucosal: mucosal ulcers; serositis: pleurisy, pericarditis; renal: renal disorder; heme: hematologic disorder; photo: photosensitivity. Immunologic disorder elements are listed separately (APL: antiphospholipid antibodies, dsDNA antibodies). Autoimmune features that are not part of systemic lupus erythematosus (SLE) criteria are listed in parentheses. **Patient was enrolled as ILE and subsequently found to have four SLE criteria. ^† LN: lupus nephritis.

ISSN: 1478-6362